Breast Cancer Clinical Trial
— DIVASOfficial title:
Delivering an Intervention to Accompany Supportive Care
The investigators are conducting a web-based study to explore the use of a mindfulness app
to improve quality of life among women with breast cancer.
Eligible participants will be asked to provide informed consent to participate and submit a
data authorization form to obtain information from the app at the end of the project.
This 12-week project will randomly assign participants to one of two groups:
Group 1 (AMT) will receive the mindfulness app right away; Group 2 (WC) will receive the
mindfulness app at the end of 12 weeks.
All participants will receive a welcome email with group designation. Participants assigned
to Group 1 (AMT) will also receive app download instructions and pass code. Group 1 will be
asked to complete the app's first 10-minute mindfulness exercise, at minimum.
Participants assigned to Group 2 (WC) will be notified that they will receive app download
instructions and pass code at the end of 12 weeks.
Regardless of group assignment, all participants will be asked to complete web-based survey
assessments 4 different times throughout the study (baseline, week 5, week 9, 12-week follow
up). The surveys will be related to quality of life, mindfulness, mobile technology, health
literacy, and chronic pain.
To encourage participation, a member of the study team will send out weekly check-in emails.
Once all data has been collected, app developers will provide the investigators with app
data for each participant, including times accessed, length of time using app. This
information will help the investigators observe which app characteristics are most useful,
as well as the optimal amount of time needed to obtain benefit from the app.
The investigators goals are to understand how using the mindfulness app compares to not
using the mindfulness app. The investigators will also observe whether the app contributes
to participants' quality of life. The investigators also want to understand more about how
women use health apps overall. This information may inform issues related to delivery of
app-based health interventions among women with breast cancer.
| Status | Completed |
| Enrollment | 112 |
| Est. completion date | June 2016 |
| Est. primary completion date | June 2016 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 25 Years to 70 Years |
| Eligibility |
Inclusion Criteria: 1. Female 2. Age = 25 3. Breast cancer diagnosis within past 5 years 4. Willing to provide locator information for follow-up contact 5. Reliable internet access 6. Ownership of smartphone or tablet with following specifications: wireless capability, running on iOS or Android operating system, current software (4.4 Android; 8.0 iOS or later), and adequate memory to run the mindfulness app (43M Android; 30.2M iOS). Exclusion Criteria: 1. Unfamiliar with mobile phones/tablets, including ability to download and register mindfulness app 2. Become unable to participate in a fully app and web-based intervention trial 3. Unwilling to complete online questionnaires 4. Unwilling to use personal phone/tablet to test intervention |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Texas Health Science Center San Antonio | San Antonio | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| The University of Texas Health Science Center at San Antonio |
United States,
Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997 Mar;15(3):974-86. — View Citation
Brooke J. SUS: a "quick and dirty" usability scale. In Jordan PW, Thomas B, McClelland IL, Weerdmeester B, eds. Usability Evaluation In Industry. Boca Raton: CRC Press; 1996:189-94.
Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003 Apr;84(4):822-48. — View Citation
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994 Mar;23(2):129-38. Review. — View Citation
Haun J, Noland-Dodd V, Varnes J, Graham-Pole J, Rienzo B, Donaldson P. Testing the BRIEF health literacy screening tool. Federal Practitioner 26(12): 24-31, 2009.
Norman CD, Skinner HA. eHEALS: The eHealth Literacy Scale. J Med Internet Res. 2006 Nov 14;8(4):e27. — View Citation
Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med. 2002 Winter;24(1):49-58. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Change in pain-related severity and interference | Measured by the Brief Pain Inventory (BPI) | Change from baseline BPI scores at 12 weeks | No |
| Other | App usability | Measured by the Systems Usability Scale | Measured at 5 weeks | No |
| Other | eHealth literacy scores | Measured by the eHealth Literacy Scale (eHEALS) | Measured at baseline | No |
| Other | Health literacy scores | Measured by the Brief Health Literacy Screen | Measured at baseline | No |
| Primary | Change in breast cancer-related quality of life scores | Measured by the Functional Assessment of Cancer Therapy-Breast (FACT-B) | Change from baseline FACT-B scores at 12 weeks | No |
| Secondary | Change in mindfulness scores | Measured by the Mindful Attention Awareness Scale (MAAS) | Change from baseline MAAS scores at 12 weeks | No |
| Secondary | Change in spiritual quality of life scores | Measured by the Functional Assessment of Chronic Illness Therapy (FACIT-SP) | Change from baseline FACIT-SP scores at 12 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |